Vitamin Shoppe (NYSE:VSI) Raised to Buy at ValuEngine

ValuEngine upgraded shares of Vitamin Shoppe (NYSE:VSI) from a hold rating to a buy rating in a research note published on Tuesday, ValuEngine reports.

Separately, Zacks Investment Research cut Vitamin Shoppe from a buy rating to a hold rating in a report on Friday, November 8th.

NYSE:VSI remained flat at $$6.50 on Tuesday. The company’s stock had a trading volume of 92,400 shares, compared to its average volume of 518,365. Vitamin Shoppe has a 1 year low of $3.32 and a 1 year high of $8.26. The company has a current ratio of 1.16, a quick ratio of 0.21 and a debt-to-equity ratio of 2.34. The stock has a market cap of $156.64 million, a price-to-earnings ratio of 24.98 and a beta of 1.58. The stock’s fifty day moving average price is $6.49 and its 200-day moving average price is $5.53.

Institutional investors have recently added to or reduced their stakes in the company. VIEX Capital Advisors LLC raised its holdings in shares of Vitamin Shoppe by 1,496.9% during the second quarter. VIEX Capital Advisors LLC now owns 2,198,449 shares of the specialty retailer’s stock worth $8,662,000 after acquiring an additional 2,060,782 shares during the period. Invesco Ltd. increased its holdings in Vitamin Shoppe by 78.7% during the 2nd quarter. Invesco Ltd. now owns 1,040,722 shares of the specialty retailer’s stock worth $4,100,000 after purchasing an additional 458,230 shares in the last quarter. Gabelli Funds LLC lifted its holdings in shares of Vitamin Shoppe by 369.7% in the third quarter. Gabelli Funds LLC now owns 516,656 shares of the specialty retailer’s stock valued at $3,369,000 after purchasing an additional 406,656 shares in the last quarter. GABELLI & Co INVESTMENT ADVISERS INC. acquired a new position in shares of Vitamin Shoppe during the third quarter worth about $2,318,000. Finally, Charles Schwab Investment Management Inc. grew its holdings in shares of Vitamin Shoppe by 92.5% during the second quarter. Charles Schwab Investment Management Inc. now owns 330,179 shares of the specialty retailer’s stock worth $1,301,000 after buying an additional 158,620 shares in the last quarter. Institutional investors own 83.26% of the company’s stock.

Vitamin Shoppe Company Profile

Vitamin Shoppe, Inc, through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products.

See Also: Why are percentage gainers important?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.